Heimdall Insights

Global Non-Insulin Diabetes Therapeutics Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Non-Insulin Diabetes Therapeutics Market was valued at $62.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 11.5% CAGR, to an estimated market size of $108 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global non-insulin diabetes therapeutics market comprises pharmaceutical agents used to manage Type 2 Diabetes Mellitus (T2DM) by improving glycemic control without the use of insulin. The scope includes GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, biguanides (metformin), and other oral or injectable non-insulin agents, while excluding insulin delivery devices and insulin-based therapies.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Non-Insulin Diabetes Therapeutics Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • GLP-1 Receptor Agonists
  • SGLT2 Inhibitors
  • DPP-4 Inhibitors
  • Biguanides & Others